UnitedHealth (UNH) is set to report Q2 earnings on Tuesday, with analysts expecting a 13.2% YoY revenue increase to $111.9 billion and adjusted earnings of $4.49 per share. Despite missing analysts' revenue expectations by 1.7% last quarter, the company added 395,000 customers, reaching a total of 54.12 million. UnitedHealth's peers, such as Centene and Molina Healthcare, have reported strong Q2 results, with revenue growth of 22.4% and 15.7%, respectively.
UnitedHealth Group (UNH), one of the leading players in the health insurance sector, is scheduled to announce its second-quarter (Q2) earnings on Tuesday, July 29, 2025. Analysts are expecting a 13.2% year-over-year (YoY) increase in revenue to $111.9 billion, with adjusted earnings per share (EPS) projected at $4.49. Despite missing revenue expectations by 1.7% in the previous quarter, the company added 395,000 customers, reaching a total of 54.12 million [2].
The stock has experienced a significant drop of 43.8% year-to-date, influenced by several challenges, including the suspension of its guidance, escalating medical costs, and a leadership shakeup that included the departure of CEO Andrew Witty [1]. Wall Street analysts anticipate a 34% decrease in EPS year-over-year, with revenues expected to increase by 13% from the year-ago quarter [1].
Recent news ahead of the earnings report includes a formal investigation by the Department of Justice (DOJ) into UnitedHealth's Medicare billing practices. The company has stated it is cooperating with both civil and criminal probes [1]. Analysts, however, remain optimistic, with Deutsche Bank's George Hill and Leerink Partners' Whit Mayo both reiterating a Buy rating despite lowering their price targets [1].
Options traders are anticipating a significant move in the stock, with a 7.97% expected earnings move immediately after the earnings announcement [1]. The stock has a Moderate Buy consensus rating based on recent analyst ratings, with an average price target implying a 23.86% upside potential [1].
UnitedHealth's peers, such as Centene and Molina Healthcare, have reported strong Q2 results, with revenue growth of 22.4% and 15.7%, respectively [2]. This suggests that the health insurance sector is performing well, although UnitedHealth's specific challenges may impact its stock performance.
As investors prepare for UnitedHealth's Q2 earnings report, it is essential to consider the broader context of the company's challenges and the sector's performance. The upcoming earnings report will provide valuable insights into UnitedHealth's financial health and its ability to navigate current challenges.
References:
[1] https://www.tipranks.com/news/unitedhealth-unh-is-about-to-report-q2-earnings-on-july-29-here-is-what-to-expect
[2] https://finance.yahoo.com/news/unitedhealth-unh-q2-earnings-expect-030644521.html
Comments
No comments yet